✦ LIBER ✦

307: Prevalence of LRRK2 mutations in Australians with Parkinson’s Disease

✍ Scribed by Julia Stevens; Yue Huang; Himesha Vandenbona; Glenda M. Halliday; George Mellick; Frank Mastaglia; John Kwok; Carolyn M. Sue

Book ID: 116674212
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 82 KB
Volume: 14
Category: Article
ISSN: 0967-5868
DOI: 10.1016/j.jocn.2007.02.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and clinical features of comm

Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease

✍ Yue Huang; Glenda M. Halliday; Himesha Vandebona; George D. Mellick; Frank Masta 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract We determined the prevalence of two common leucine‐rich repeat kinase 2 (LRRK2) gene mutations in Australian patients with Parkinson's disease (PD). Of 830 affected patients, eight were heterozygous for the G2019S mutation, and two were heterozygous for the R1441H (4,322 G > A) mutation

LRRK2 mutations in Basque patients with

LRRK2 mutations in Basque patients with Parkinson's disease

✍ Juan J Zarranz; Juan Carlos Gómez-Esteban 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 54 KB

High prevalence of LRRK2 mutations in fa

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

✍ Joaquim J. Ferreira; Leonor Correia Guedes; Mário Miguel Rosa; Miguel Coelho; Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Mutations in the __Leucine‐Rich Repeat Kinase 2__ (__LRRK2__) gene are the most frequent known cause of Parkinson's disease (PD), but their prevalence varies markedly between populations. Here we studied the frequency and associated phenotype of four recurrent __LRRK2__ mutations (R1441

Prevalence and clinical features of LRRK

Prevalence and clinical features of LRRK2 mutations in patients with Parkinson’s disease in southern Spain

✍ L. Gao; P. Gómez-Garre; F. J. Díaz-Corrales; F. Carrillo; M. Carballo; A. Palomi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

LRRK2 mutations in Basque patients with

LRRK2 mutations in Basque patients with Parkinson's disease – Authors' reply

✍ Daniel G Healy 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 46 KB

Molecular biology changes associated wit

Molecular biology changes associated with LRRK2 mutations in Parkinson's disease

✍ Yi Wei Lu; Eng-King Tan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract Parkinson's disease (PD) is characterized by progressive dopaminergic neuronal loss in the substantia nigra. The recent discovery of __leucine‐rich‐repeat kinase 2__ gene (__LRRK2__) mutations in PD is significant because these mutations are the most common cause of autosomal dominant P